| Title | Prostate Cancer |
| Abbreviation | Prostate Cancer |
| Publication Type | Journal |
| Subject Area, Categories, Scope | Urology (Q2); Cancer Research (Q3); Oncology (Q3) |
| h-index | 16 |
| Overall Rank/Ranking | 10402 |
| SCImago Journal Rank (SJR) | 0.56 |
| Impact Score | 1.36 |
| Publisher | John Wiley and Sons Ltd |
| Country | United Kingdom |
| ISSN | 20903111, 2090312X |
| Best Quartile | Q2 |
| Coverage History | 2011, 2013-2024 |
Prostate Cancer is a journal covering the technologies/fields/categories related to Urology (Q2); Cancer Research (Q3); Oncology (Q3). It is published by John Wiley and Sons Ltd. The overall rank of Prostate Cancer is 10402. According to SCImago Journal Rank (SJR), this journal is ranked 0.56. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 16. The best quartile for this journal is Q2.
The ISSN of Prostate Cancer journal is 20903111, 2090312X. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Prostate Cancer is cited by a total of 20 articles during the last 3 years (Preceding 2024).
The Impact IF 2024 of Prostate Cancer is 1.36, which is computed in 2025 as per its definition. Prostate Cancer IF is increased by a factor of 0.6 and approximate percentage change is 78.95% when compared to preceding year 2023, which shows a rising trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2024 of Prostate Cancer is 1.36. If the same upward trend persists, Impact IF may rise in 2025 as well.
| Year | Impact IF |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.36 |
| 2023 | 0.76 |
| 2022 | 1.17 |
| 2021 | 1.77 |
| 2020 | 1.83 |
| 2019 | 3.20 |
| 2018 | 2.50 |
| 2017 | 2.68 |
| 2016 | 2.58 |
| 2015 | 0.25 |
| 2014 | 2.00 |
Prostate Cancer has an h-index of 16. It means 16 articles of this journal have more than 16 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Prostate Cancer is 20903111, 2090312X. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Prostate Cancer is 10402. According to SCImago Journal Rank (SJR), this journal is ranked 0.56. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
| Year | SJR |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 0.56 |
| 2023 | 0.305 |
| 2022 | 0.364 |
| 2021 | 0.321 |
| 2020 | 0.377 |
| 2019 | 0.703 |
| 2018 | 0.877 |
| 2017 | 0.890 |
| 2016 | 1.617 |
| 2015 | 0.150 |
| 2014 | 0.130 |
| Year | Ranking |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 10402 |
| 2023 | 15569 |
| 2022 | 13362 |
| 2021 | 14180 |
| 2020 | 12682 |
| 2019 | 6939 |
| 2018 | 5239 |
| 2017 | 5121 |
| 2016 | 2071 |
| 2015 | 21046 |
| 2014 | 22804 |
Prostate Cancer is published by John Wiley and Sons Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2011, 2013-2024. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Prostate Cancer is Prostate Cancer. This abbreviation ('Prostate Cancer') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Urology (Q2); Cancer Research (Q3); Oncology (Q3), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Prostate Cancer latest impact IF is 1.36. It's evaluated in the year 2024. The highest and the lowest impact IF or impact score of this journal are 3.20 (2019) and 0.25 (2015), respectively, in the last 11 years. Moreover, its average IS is 1.83 in the previous 11 years.
The Prostate Cancer has an SJR (SCImago Journal Rank) of 0.56, according to the latest data. It is computed in the year 2025. In the past 11 years, this journal has recorded a range of SJR, with the highest being 1.617 in 2016 and the lowest being 0.130 in 2014. Furthermore, the average SJR of the Prostate Cancer over the previous 11-year period stands at 1.83.
The latest h-index of the Prostate Cancer is 16.
The Prostate Cancer is published by the John Wiley and Sons Ltd, with its country of publication being the United Kingdom.
The Prostate Cancer is currently ranked 10402 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 11 years, this journal has experienced varying rankings, reaching its highest position of 2071 in 2016 and its lowest position of 22804 in 2014.
The standard ISO4 abbreviation for the Prostate Cancer is Prostate Cancer.
Prostate Cancer is classified as a journal that the John Wiley and Sons Ltd publishes.
The Prostate Cancer encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Prostate Cancer is assigned the following International Standard Serial Numbers (ISSN): 20903111, 2090312X.
The best quartile for the Prostate Cancer is Q2 (2024).
The Prostate Cancer coverage history can be summarized as follows: 2011, 2013-2024.
| Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
|---|---|---|---|---|---|
| Journal of Business Economics and Management | journal | 9811 | Vilnius Gediminas Technical University | 55 | 2.84 |
| Journal of Academic Ethics | journal | 8704 | Springer Netherlands | 34 | 4.04 |
| Current Sociology | journal | 5151 | SAGE Publications Ltd | 86 | 3.02 |
| IEEE/OSA Journal of Display Technology | journal | 12809 | IEEE Computer Society | 68 | 0.00 |
| Criminal Justice Review | journal | 10284 | SAGE Publications Inc. | 46 | 1.91 |
| Istanbul University - Journal of Electrical and Electronics Engineering | journal | 24654 | University of Istanbul | 0 | 0.00 |
| Journal, Indian Academy of Clinical Medicine | journal | 28559 | Indian Academy of Clinical Medicine | 16 | 0.10 |
| British Journal of Special Education | journal | 14055 | Wiley-Blackwell Publishing Ltd | 45 | 1.43 |
| Howard Journal of Communications | journal | 14582 | Taylor and Francis Ltd. | 42 | 1.27 |
| Studies in Continuing Education | journal | 4850 | Routledge | 44 | 3.35 |
| Year | Impact Score (IS) |
|---|---|
| 2025/2026 | Coming Soon |
| 2024 | 1.36 |
| 2023 | 0.76 |
| 2022 | 1.17 |
| 2021 | 1.77 |
| 2020 | 1.83 |
| 2019 | 3.20 |
| 2018 | 2.50 |
| 2017 | 2.68 |
| 2016 | 2.58 |
| 2015 | 0.25 |
| 2014 | 2.00 |
